Financhill
Sell
22

ADAP Quote, Financials, Valuation and Earnings

Last price:
$0.28
Seasonality move :
-12.29%
Day range:
$0.28 - $0.30
52-week range:
$0.20 - $1.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.40x
P/B ratio:
6.03x
Volume:
664.5K
Avg. volume:
1.3M
1-year change:
-72.38%
Market cap:
$74.7M
Revenue:
$178M
EPS (TTM):
-$0.31

Earnings Data

Next earnings date for ADAP
Aug 12
2025
Most recent earnings per share
-$0.18
Missed by $0.02
(May 13/2025)
Consensus Estimate
-$0.17
(May 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ADAP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/12/2025 Q2 $11M -- -- -$0.14 --
05/13/2025 Q1 $6.6M $7.3M -$0.18 -$0.17 -$0.02
03/20/2025 Q4 $8.2M $3.2M -$0.31 -$0.15 -$0.16
11/13/2024 Q3 $20.5M $40.9M -$0.06 -$0.18 $0.12
08/12/2024 Q2 $44.8M $128.2M $0.24 -$0.20 $0.44
05/15/2024 Q1 $20.5M $5.7M -$0.18 -$0.20 $0.02
03/06/2024 Q4 $26M $231K -$0.18 -$0.17 -$0.01
11/08/2023 Q3 -- -- -$0.18 -$0.17 -$0.01
08/09/2023 Q2 -- -- -$0.12 -$0.18 $0.06
05/12/2023 Q1 -- -- $0.01 -$0.16 $0.16
03/06/2023 Q4 -- -- -$0.18 -$0.25 $0.07
11/08/2022 Q3 -- -- -$0.24 -$0.27 $0.03
08/04/2022 Q2 -- -- -$0.30 -$0.27 -$0.03
05/09/2022 Q1 -- -- -$0.30 -$0.26 -$0.04
03/14/2022 Q4 -- -- -$0.24 -- --
11/04/2021 Q3 -- -- -$0.30 -$0.27 -$0.04
08/09/2021 Q2 -- -- -$0.24 -$0.24 $0.00
05/06/2021 Q1 -- -- -$0.24 -$0.25 $0.01
02/25/2021 Q4 -- -- -$0.24 -- --
11/05/2020 Q3 -- -- -$0.24 -- --
08/06/2020 Q2 -- -- -$0.24 -- --
05/14/2020 Q1 -- -- -$0.24 -- --
02/27/2020 Q4 -- -- -$0.30 -- --
11/06/2019 Q3 -- -- -$0.36 -- --
08/01/2019 Q2 -- -- -$0.42 -- --
05/06/2019 Q1 -- -- -$0.24 -- --
02/27/2019 Q4 -- -- -$0.36 -- --
11/06/2018 Q3 -- -- $0.06 -- --
08/02/2018 Q2 -- -- -$0.48 -- --
05/09/2018 Q1 -- -- -$0.24 -- --
03/15/2018 Q4 -- -- -$0.30 -- --
11/02/2017 Q3 -- -- -$0.01 -- --
08/03/2017 Q2 -- -- -$0.24 -- --
03/31/2017 Q1 -- -- -$0.30 -- --
12/31/2016 Q4 -- -- -$0.24 -- --
09/30/2016 Q3 -- -- -$0.24 -- --
06/30/2016 Q2 -- -- -$0.30 -- --
03/31/2016 Q1 -- -- -$0.24 -- --
09/30/2015 Q3 -- -- -$0.02 -- --

Adaptimmune Therapeutics PLC Earnings Questions

  • How Much did Adaptimmune Therapeutics PLC Generate in Revenue Last Quarter?

    Adaptimmune Therapeutics PLC reported $7.3M worth of top line sales in its most recent quarter.

  • Did Adaptimmune Therapeutics PLC Beat Earnings Last Quarter?

    Adaptimmune Therapeutics PLC announced earnings per share of -$0.18 which represents a miss of analyst forecast a -$0.17 per share.

  • Is Adaptimmune Therapeutics PLC Profitable?

    Adaptimmune Therapeutics PLC reported $6.4M that represents $0.02 per share over the last quarter.

  • What is the Analyst Consensus for Adaptimmune Therapeutics PLC EPS Next Year?

    Adaptimmune Therapeutics PLC's earnings are forecast to decrease from -$0.30 per share to -$0.14 per share next year representing a decrease of -66.33%.

  • When is Adaptimmune Therapeutics PLC's Earnings Date?

    Adaptimmune Therapeutics PLC's next earnings date is August 12, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Exxon Stock Be in 5 Years?
Where Will Exxon Stock Be in 5 Years?

For sure Exxon Mobil (NYSE: XOM) is no hyped-up AI…

How High Will Dollar General Stock Go?
How High Will Dollar General Stock Go?

Shares of Dollar General (NYSE:DG) have risen significantly in recent…

How High Can Planet Labs Go Now?
How High Can Planet Labs Go Now?

Planet Labs (NYSE:PL) has been a much-talked-about stock for years,…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 40x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 48x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
19
LULU alert for Jun 9

Lululemon Athletica [LULU] is down 2.36% over the past day.

Buy
51
DOCU alert for Jun 10

Docusign [DOCU] is up 4.37% over the past day.

Sell
19
BRZE alert for Jun 10

Braze [BRZE] is up 3.06% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock